Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application.

Barbulescu, Andrei; Sjölander, Arvid; Delcoigne, Bénédicte; Askling, Johan; Frisell, Thomas

Barbulescu, Andrei; Sjölander, Arvid; Delcoigne, Bénédicte; Askling, Johan; Frisell, Thomas.

Afiliação

Barbulescu A; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Sjölander A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Delcoigne B; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Askling J; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Frisell T; Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.

Rheumatology (Oxford) ; 62(10): 3391-3399, 2023 10 03.

Article em En | MEDLINE | ID: mdl-36821426

Assuntos

Antirreumáticos; Artrite Reumatoide; Humanos; Glucocorticoides/uso terapêutico; Estudos Prospectivos; Fatores de Risco; Artrite Reumatoide/complicações; Prednisona/efeitos adversos; Antirreumáticos/uso terapêutico

Palavras-chave

RA; glucocorticoids; infections; marginal structural models

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google